In our study, FDX1, GLS, DLAT, MTF1 and LIPT1 were positively associated with main immune checkpoint genes expression and negatively correlated with the infiltration level of Tregs, which suggesting that they could be a positive biomarker for the prognosis of BC patients treated by immunotherapy. This evidence concerns the gene DLAT and breast cancer.